Detail Cantuman Kembali
Studi Penggunaan Obat Pada Pasien Infark Miokard (Peneltian dilakukan di Rumkital Dr. Ramelan Surabaya)
- Bagikan:
Mycardial Infarcation (MI) is the leading cause of death in the United States and in most indutrialized nayions throughout the world. the incidence of MI increases with age: however, the actual incidence is dependent on predisposing risk factors for atherosclerosis. most of the drugs used in the treatment of myocardial infarction potentially have adverse effects of bleeding and hypotension that required monitoring to the use of the drugs. selection of drugs will graetly affect the succesfull of therapy. the aims of this study were to determine the drug utilization, identifying drug related problems, and clinical outcome in patienswith myocardial infarction. the clinical outcome can be seen from the patient's sympthoms, such as relieved chest pain or tightness. verbal description scales was prospective observational study with time limited sampling method.
the result showed that drugs used ny patients were oxygenation (85%), vasodilator nitrates (100%), opioid analgesics (3%), antiplatelet (21%), beta blockers (48%), ACE Inhibitors (33%), and ARBs (15%). there were actual drug related problems accur, such as decrease blood pressure in 1 patient and headache in 2 patients due to the use of ISDN; and drycough in 2 patients due to the use of ACE Inhibitors. clinical outcome was achieved after therapy in patients with myocardial infarction is chest pain relieved (100%). from the laboratory data SGOT, only 23 patients who performed the examination; 13 patients showed the normal range, i patient changed from exceed normal to normal, and 9 patients still exceed normal because measurements were not taken again.
Argasetya. Lucky - Personal Name
6B.S Arg s
6B.S Arg s
Text
Indonesia
Fakultas Farmasi UNAIR
2012
Surabaya
xviii; 110p.; 21cm
LOADING LIST...
LOADING LIST...